# JDP2

## Overview
JDP2 (Jun dimerization protein 2) is a gene that encodes a transcription factor belonging to the basic leucine zipper (bZIP) family, which plays a pivotal role in regulating gene expression. The protein encoded by JDP2 is characterized by its ability to form homodimers and heterodimers with other bZIP proteins, influencing various cellular processes such as differentiation, proliferation, and apoptosis. As a transcriptional repressor, JDP2 modulates chromatin structure and transcriptional activity by interacting with histone deacetylases and other transcription factors. It is involved in maintaining reactive oxygen species (ROS) homeostasis and has been implicated in several pathological conditions, including cancer and cardiac diseases, where it can function as both a tumor suppressor and an oncogene depending on the context (Nakade2007JDP2; Tanigawa2013Jun; BittonWorms2010The).

## Structure
JDP2 (Jun dimerization protein 2) is a member of the basic leucine zipper (bZIP) family of transcription factors. It contains a leucine zipper domain that facilitates dimerization and a basic region for DNA binding. The protein can form homodimers and heterodimers with other bZIP proteins, such as members of the Jun family and ATF-2, but not with Fos (Yamasaki2005Jun). JDP2 is a 21-kDa protein composed of 163 amino acids, with a high degree of homology across species, including mouse, rat, human, and equine (Yamasaki2005Jun).

The protein's structure includes a histone-binding domain located between amino acids 35 and 70, which is essential for its interaction with core histones, particularly histone H3 (Yamasaki2005Jun). The DNA-binding domain is situated in the basic region of the bZIP motif between amino acids 70 and 102 (Yamasaki2005Jun). JDP2 is phosphorylated by JNKs on threonine residue 148, which is crucial for its repressor function (Yamasaki2005Jun; Jonak2017cJUN).

JDP2 lacks a C-terminal activation domain, which contributes to its role as a transcriptional repressor (Wardell2002Jun). The protein's ability to interact with other transcription factors and coactivators, such as pCAF and p300/CBP, further influences its regulatory functions (Wardell2002Jun; Yamasaki2005Jun).

## Function
Jun dimerization protein 2 (JDP2) is a transcription factor that plays a significant role in regulating gene expression in healthy human cells. It is a member of the AP-1 family and functions primarily as a transcriptional repressor, although it can also act as a coactivator depending on the context. JDP2 is involved in various cellular processes, including differentiation, proliferation, and apoptosis, by modulating chromatin structure and transcriptional activity (Nakade2007JDP2; Pan2010Suppression).

JDP2 exerts its effects by inhibiting histone acetylation, which is crucial for transcription regulation. It achieves this by recruiting histone deacetylase 3 (HDAC3) to specific gene promoters, such as the C/EBPd gene, thereby repressing transcription and influencing adipocyte differentiation (Nakade2007JDP2). In the context of cell cycle regulation, JDP2 suppresses cell proliferation by downregulating cyclin-A2 expression, which is essential for cell cycle progression (Pan2010Suppression).

JDP2 also plays a role in maintaining reactive oxygen species (ROS) homeostasis by being a critical component of the Nrf2/MafK complex. It enhances the DNA-binding activity of this complex to antioxidant response elements (AREs), promoting the transcription of genes involved in antioxidant responses (Tanigawa2013Jun).

## Clinical Significance
JDP2 (Jun dimerization protein 2) plays a complex role in various diseases, particularly in cancer and cardiac conditions. In liver cancer, specifically hepatocellular carcinoma (HCC), JDP2 has been shown to potentiate tumor development. Transgenic mice expressing JDP2 in the liver exhibited increased tumor size, number, and severity, suggesting that JDP2 may enhance compensatory proliferative responses and inflammation during cancer progression (BittonWorms2010The). 

In the context of heart disease, JDP2 is implicated in heart failure (HF) and myocardial infarction (MI). Overexpression of JDP2 in the heart leads to ventricular dysfunction and increased mortality in mice, indicating its role in adverse cardiac remodeling and progression to HF (Euler2021JDP2).

JDP2 also exhibits dual roles in cancer, acting as both a tumor suppressor and an oncogene. In prostate cancer, JDP2 expression is higher in normal tissues compared to tumor tissues, suggesting a tumor-suppressive function (Heinrich2004The). Conversely, in pancreatic cancer, downregulation of JDP2 is associated with poor prognosis and metastasis, indicating its potential as a prognostic biomarker (Luo2018Identification). 

Overall, alterations in JDP2 expression or its interactions can significantly impact disease progression, highlighting its clinical significance.

## Interactions
JDP2 (Jun dimerization protein 2) is involved in various protein-protein and protein-DNA interactions that influence transcriptional regulation. JDP2 forms heterodimeric complexes with members of the AP-1 family, including c-Jun, JunB, and JunD, enhancing or repressing their transcriptional activities. It binds to the AP-1 site of the c-jun promoter and enhances c-Jun binding, but also inhibits c-Jun's transcriptional activation in NIH 3T3 cells (Aronheim1997Isolation).

JDP2 interacts with histone deacetylases (HDACs), particularly HDAC3 and HDAC6, through its N-terminal bZIP motif. These interactions are crucial for its role in transcription repression, as JDP2 recruits HDACs to target promoters, inhibiting histone acetylation and promoting chromatin condensation (Jin2002JDP2; DarlyukSaadon2012The).

In response to genotoxic stress, JDP2 forms a complex with β-catenin and PRMT5, which is essential for regulating glutathione metabolism and maintaining cellular redox balance. This complex facilitates the transcriptional upregulation of genes involved in glutathione metabolism, contributing to cancer cell resistance to genotoxic stress (Cao2019Genotoxic).

JDP2 also interacts with CHOP10, forming a complex that enhances transcription from promoters containing TPA response elements, while counteracting CHOP10's pro-apoptotic activity (WeidenfeldBaranboim2008TREdependent).


## References


[1. (Wardell2002Jun) Suzanne E. Wardell, Viroj Boonyaratanakornkit, James S. Adelman, Ami Aronheim, and Dean P. Edwards. Jun dimerization protein 2 functions as a progesterone receptor n-terminal domain coactivator. Molecular and Cellular Biology, 22(15):5451–5466, August 2002. URL: http://dx.doi.org/10.1128/mcb.22.15.5451-5466.2002, doi:10.1128/mcb.22.15.5451-5466.2002. This article has 81 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.22.15.5451-5466.2002)

[2. (Cao2019Genotoxic) Lixue Cao, Geyan Wu, Jinrong Zhu, Zhanyao Tan, Dongni Shi, Xingui Wu, Miaoling Tang, Ziwen Li, Yameng Hu, Shuxia Zhang, Ruyuan Yu, Shuang Mo, Jueheng Wu, Erwei Song, Mengfeng Li, Libing Song, and Jun Li. Genotoxic stress-triggered β-catenin/jdp2/prmt5 complex facilitates reestablishing glutathione homeostasis. Nature Communications, August 2019. URL: http://dx.doi.org/10.1038/s41467-019-11696-7, doi:10.1038/s41467-019-11696-7. This article has 33 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-019-11696-7)

[3. (Aronheim1997Isolation) Ami Aronheim, Ebrahim Zandi, Hanjo Hennemann, Stephen J. Elledge, and Michael Karin. Isolation of an ap-1 repressor by a novel method for detecting protein-protein interactions. Molecular and Cellular Biology, 17(6):3094–3102, June 1997. URL: http://dx.doi.org/10.1128/mcb.17.6.3094, doi:10.1128/mcb.17.6.3094. This article has 374 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.17.6.3094)

[4. (Tanigawa2013Jun) S Tanigawa, C H Lee, C S Lin, C C Ku, H Hasegawa, S Qin, A Kawahara, Y Korenori, K Miyamori, M Noguchi, L H Lee, Y C Lin, C L Steve Lin, Y Nakamura, C Jin, N Yamaguchi, R Eckner, D-X Hou, and K K Yokoyama. Jun dimerization protein 2 is a critical component of the nrf2/mafk complex regulating the response to ros homeostasis. Cell Death &amp; Disease, 4(11):e921–e921, November 2013. URL: http://dx.doi.org/10.1038/cddis.2013.448, doi:10.1038/cddis.2013.448. This article has 52 citations.](https://doi.org/10.1038/cddis.2013.448)

[5. (BittonWorms2010The) Keren Bitton-Worms, Eli Pikarsky, and Ami Aronheim. The ap-1 repressor protein, jdp2, potentiates hepatocellular carcinoma in mice. Molecular Cancer, March 2010. URL: http://dx.doi.org/10.1186/1476-4598-9-54, doi:10.1186/1476-4598-9-54. This article has 37 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1186/1476-4598-9-54)

[6. (Euler2021JDP2) Gerhild Euler, Jens Kockskämper, Rainer Schulz, and Mariana S. Parahuleva. Jdp2, a novel molecular key in heart failure and atrial fibrillation? International Journal of Molecular Sciences, 22(8):4110, April 2021. URL: http://dx.doi.org/10.3390/ijms22084110, doi:10.3390/ijms22084110. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.3390/ijms22084110)

[7. (Luo2018Identification) Wei-Ming Luo, Zheng-Yu Wang, and Xin Zhang. Identification of four differentially methylated genes as prognostic signatures for stage i lung adenocarcinoma. Cancer Cell International, April 2018. URL: http://dx.doi.org/10.1186/s12935-018-0547-6, doi:10.1186/s12935-018-0547-6. This article has 16 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12935-018-0547-6)

[8. (Nakade2007JDP2) K Nakade, J Pan, A Yoshiki, H Ugai, M Kimura, B Liu, H Li, Y Obata, M Iwama, S Itohara, T Murata, and K K Yokoyama. Jdp2 suppresses adipocyte differentiation by regulating histone acetylation. Cell Death &amp; Differentiation, 14(8):1398–1405, April 2007. URL: http://dx.doi.org/10.1038/sj.cdd.4402129, doi:10.1038/sj.cdd.4402129. This article has 47 citations.](https://doi.org/10.1038/sj.cdd.4402129)

[9. (Yamasaki2005Jun) T. Yamasaki, M. Noguchi, B. Liu, K. Nakade, P- Wang, T. Murata, and K. Yokoyama. Jun dimerization protein 2: a multifunctional transcription factor in mammalian cells. Current Genomics, 6(5):351–364, August 2005. URL: http://dx.doi.org/10.2174/1389202054750194, doi:10.2174/1389202054750194. This article has 1 citations and is from a peer-reviewed journal.](https://doi.org/10.2174/1389202054750194)

[10. (Jonak2017cJUN) Carrie R. Jonak, Nancy M. Lainez, Lacey L. Roybal, Alexa D. Williamson, and Djurdjica Coss. C-jun dimerization protein 2 (jdp2) is a transcriptional repressor of follicle-stimulating hormone β (fshβ) and is required for preventing premature reproductive senescence in female mice. Journal of Biological Chemistry, 292(7):2646–2659, February 2017. URL: http://dx.doi.org/10.1074/jbc.M116.771808, doi:10.1074/jbc.m116.771808. This article has 29 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M116.771808)

[11. (Jin2002JDP2) Chunyuan Jin, Hongjie Li, Takehide Murata, Kailai Sun, Masami Horikoshi, Robert Chiu, and Kazunari K. Yokoyama. Jdp2, a repressor of ap-1, recruits a histone deacetylase 3 complex to inhibit the retinoic acid-induced differentiation of f9 cells. Molecular and Cellular Biology, 22(13):4815–4826, July 2002. URL: http://dx.doi.org/10.1128/mcb.22.13.4815-4826.2002, doi:10.1128/mcb.22.13.4815-4826.2002. This article has 82 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.22.13.4815-4826.2002)

[12. (Pan2010Suppression) J Pan, K Nakade, Y-C Huang, Z-W Zhu, S Masuzaki, H Hasegawa, T Murata, A Yoshiki, N Yamaguchi, C-H Lee, W-C Yang, E-M Tsai, Y Obata, and K K Yokoyama. Suppression of cell-cycle progression by jun dimerization protein-2 (jdp2) involves downregulation of cyclin-a2. Oncogene, 29(47):6245–6256, August 2010. URL: http://dx.doi.org/10.1038/onc.2010.355, doi:10.1038/onc.2010.355. This article has 41 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/onc.2010.355)

[13. (WeidenfeldBaranboim2008TREdependent) K. Weidenfeld-Baranboim, K. Bitton-Worms, and A. Aronheim. Tre-dependent transcription activation by jdp2-chop10 association. Nucleic Acids Research, 36(11):3608–3619, May 2008. URL: http://dx.doi.org/10.1093/nar/gkn268, doi:10.1093/nar/gkn268. This article has 34 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkn268)

[14. (DarlyukSaadon2012The) Ilona Darlyuk-Saadon, Keren Weidenfeld-Baranboim, Kazunari K. Yokoyama, Tsonwin Hai, and Ami Aronheim. The bzip repressor proteins, c-jun dimerization protein 2 and activating transcription factor 3, recruit multiple hdac members to the atf3 promoter. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms, 1819(11–12):1142–1153, November 2012. URL: http://dx.doi.org/10.1016/j.bbagrm.2012.09.005, doi:10.1016/j.bbagrm.2012.09.005. This article has 41 citations.](https://doi.org/10.1016/j.bbagrm.2012.09.005)

[15. (Heinrich2004The) Ronit Heinrich, Erella Livne, Offer Ben-Izhak, and Ami Aronheim. The c-jun dimerization protein 2 inhibits cell transformation and acts as a tumor suppressor gene. Journal of Biological Chemistry, 279(7):5708–5715, February 2004. URL: http://dx.doi.org/10.1074/jbc.M307608200, doi:10.1074/jbc.m307608200. This article has 78 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M307608200)